Psychotic disorder in a patient with central and extrapontine myelinolysis

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 3, 2007, Pages 320-322

  Lim, Leslie ^a   Krystal, Andrew ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Basal ganglia; Central and extrapontine myelinolysis; Parkinson's disease; Psychosis; Risperidone

Indexed keywords

RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; EXTRAPONTINE MYELINOLYSIS; FEMALE; HUMAN; METABOLIC ENCEPHALOPATHY; PSYCHOSIS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; BACLOFEN; FEMALE; FLUVOXAMINE; GABA AGONISTS; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MOVEMENT DISORDERS; MYELINOLYSIS, CENTRAL PONTINE; PSYCHOTIC DISORDERS; QUADRIPLEGIA; RISPERIDONE; TRIHEXYPHENIDYL;

EID: 34247582347     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01648.x     Document Type: Article

References (17)

1. Laureno R, Karp BI. Pontine and extrapontine myelinolysis following rapid correction of hyponatraemia. Lancet 1988 72 : 439 440.
2. Pirzada NA, Ali I. Central pontine myelinolysis. Mayo Clin. Proc. 2001 76 : 559 562.
3. Federlein T, Postert T, Muller T. Central pontine myelinolysis causes bilateral loss of deep sensitivity and pseudochoreoathetosis. J. Neurol. Neurosurg. Psychiatry 1998 65 : 607 608.
4. Seiser A, Schwarz S, Aichinger-Steiner MM, Funk G, Schnider P, Brainin M. Parkinsonism and dystonia in central pontine and extrapontine myelinolysis. J. Neurol. Neurosurg. Psychiatry 1998 65 : 119 121.
5. Salerno S, Kurlan R, Joy S, Shoulson I. Dystonia in central pontine myelinolysis without evidence of extrapontine myelinolysis. J. Neurol. Neurosurg. Psychiatry 1993 56 : 1221 1223.
6. Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979 102 : 361 385.
7. Vermetten E, Rutten S, Boon P, Hofman P. Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis. Gen. Hosp. Psychiatry 1999 21 : 296 302.
8. Price H, Marsel-Mesulam M. Behavioural manifestations of central pontine myelinolysis. Arch. Neurol. 1987 44 : 671 673.
9. Chalela J, Kattah J. Catatonia due to central pontine and extrapontine myelinolysis: Case report. J. Neurol. Neurosurg. Psychiatry 1999 67 : 692 693.
10. Cummings JL. Behavioral complications of drug treatment in Parkinson's disease. J. Am. Geriatr. Soc. 1991 39 : 708 716.
11. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: Drug-induced psychiatric states. In : Weiner WJ, Lang AE (eds). Behavioral Neurology of Movement Disorders: Advances in Neurology, Vol. 65. Raven Press, New York, 1995 115 138.
12. Swayze VW, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study. Biol. Psychiatry 1992 31 : 221 240.
13. Tauscher-Wisniewski S, Tauscher J, Logan J, Christensen BK, Miku DJ, Zipursky RB. Caudate volume changes in first episode psychosis parallel the effects of normal ageing: A 5-year follow-up study. Schizophr. Res. 2000 58 : 185 188.
14. Taylor S, Christensen JD, Holcomb JM, Garver DL. Volume increases in striatum associated with positive symptom reduction in schizophrenia: A preliminary observation. Psychiatry Res. 2005 140 : 85 89.
15. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988 1 : 179 186.
16. Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J. Neurol. 2005 252 : 753 764.
17. Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations. J. Geriatr. Psychiatry Neurol. 2002 15 : 156 170.